Feng Bi
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 47
- Colorectal Cancer Treatments and Studies 26
- Cancer Treatment and Pharmacology 9
-
- Gastric Cancer Management and Outcomes 19
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Qiulin Tang (33 shared papers)Qiyong Gong (22 shared papers)Hongwei Xia (19 shared papers)Xiaoqi Huang (14 shared papers)Huanji Xu (13 shared papers)Su Lui (11 shared papers)Gongmin Zhu (3 shared papers)Meng Qiu (29 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Annals of Oncology (8 papers)Oncotarget (5 papers)Medical Oncology (4 papers)The Oncologist (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Feng Bi
138 papers receiving 4.6k citations
Feng Bi's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 925
- Oncology 1.3k
- Cognitive Neuroscience 654
- Hepatology 209
- Pulmonary and Respiratory Medicine 765
Countries citing papers authored by Feng Bi
This map shows the geographic impact of Feng Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Bi more than expected).
Fields of papers citing papers by Feng Bi
This network shows the impact of papers produced by Feng Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Bi. The network helps show where Feng Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 578 |
| 2 | Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer Hit paper breakdown → | 2021 | 296 |
| 3 | Ferroptosis in the tumor microenvironment: perspectives for immunotherapy Hit paper breakdown → | 2021 | 241 |
| 4 | 2017 | 183 | |
| 5 | 2011 | 153 | |
| 6 | 2010 | 147 | |
| 7 | 2015 | 140 | |
| 8 | 2015 | 136 | |
| 9 | 2015 | 131 | |
| 10 | 2016 | 120 | |
| 11 | 2014 | 117 | |
| 12 | 2011 | 110 | |
| 13 | 2013 | 98 | |
| 14 | 2018 | 98 | |
| 15 | 2016 | 92 | |
| 16 | 2014 | 86 | |
| 17 | 2015 | 79 | |
| 18 | 2020 | 75 | |
| 19 | 2016 | 75 | |
| 20 | 2009 | 69 |
About Feng Bi
Feng Bi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 142 papers that have together received 4.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (26 papers), Gastric Cancer Management and Outcomes (19 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Treatment and Pharmacology (9 papers), MicroRNA in disease regulation (8 papers), Functional Brain Connectivity Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Cancer Research (925 citations), Oncology (1.3k citations), Cognitive Neuroscience (654 citations), Hepatology (209 citations) and Pulmonary and Respiratory Medicine (765 citations). Feng Bi has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qiulin Tang, Qiyong Gong, Hongwei Xia, Xiaoqi Huang, Huanji Xu, Su Lui, Gongmin Zhu, Meng Qiu, Lijiao Pei and Di Ye. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncotarget, Medical Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.